NO934381L - Terapeutiske sammensetninger for osteoinduksjon - Google Patents

Terapeutiske sammensetninger for osteoinduksjon

Info

Publication number
NO934381L
NO934381L NO934381A NO934381A NO934381L NO 934381 L NO934381 L NO 934381L NO 934381 A NO934381 A NO 934381A NO 934381 A NO934381 A NO 934381A NO 934381 L NO934381 L NO 934381L
Authority
NO
Norway
Prior art keywords
osteoinduction
therapeutic compositions
mammal
safe
effective amount
Prior art date
Application number
NO934381A
Other languages
English (en)
Other versions
NO934381D0 (no
Inventor
Roger Lee Stone
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO934381D0 publication Critical patent/NO934381D0/no
Publication of NO934381L publication Critical patent/NO934381L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

En fremgangsmåte for å generere ny benvekst i et pattedyr omfattende å administrere til pattedyret en sikker og effektiv mengde av en vitamin D-for-bindelse i kombinasjon med en sikker og effektiv mengde av et osteoinduktivt ekstrakt eller minst ett benmorfogent protein.
NO934381A 1991-06-05 1993-12-02 Terapeutiske sammensetninger for osteoinduksjon NO934381L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70962191A 1991-06-05 1991-06-05
US85611092A 1992-03-27 1992-03-27
PCT/US1992/004356 WO1992021365A1 (en) 1991-06-05 1992-05-26 Therapeutic compositions for osteoinduction

Publications (2)

Publication Number Publication Date
NO934381D0 NO934381D0 (no) 1993-12-02
NO934381L true NO934381L (no) 1994-01-31

Family

ID=27108286

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934381A NO934381L (no) 1991-06-05 1993-12-02 Terapeutiske sammensetninger for osteoinduksjon

Country Status (13)

Country Link
EP (1) EP0587751A1 (no)
JP (1) JPH06508140A (no)
AU (1) AU667815B2 (no)
BR (1) BR9206110A (no)
CA (1) CA2110410C (no)
CZ (1) CZ282231B6 (no)
IE (1) IE921812A1 (no)
NO (1) NO934381L (no)
NZ (1) NZ243018A (no)
PT (1) PT100567A (no)
RU (1) RU2107512C1 (no)
SK (1) SK136693A3 (no)
WO (1) WO1992021365A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674844A (en) * 1991-03-11 1997-10-07 Creative Biomolecules, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
US7056882B2 (en) 1991-03-11 2006-06-06 Curis, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
DE69233559T2 (de) * 1991-08-30 2006-08-31 Curis, Inc., Cambridge Osteogenische proteine in der behandlung von metabolischen knochenkrankheiten
US6071695A (en) * 1992-02-21 2000-06-06 Creative Biomolecules, Inc. Methods and products for identification of modulators of osteogenic protein-1 gene expression
EP0691849B1 (en) * 1993-03-29 1999-06-02 ZymoGenetics, Inc. Oesteoblast growth stimulating compostion containing pdgf and vitamin d
CA2191583C (en) * 1994-06-07 2007-03-27 Engin Ozkaynak Methods and compositions for modulating morphogenic protein expression
US7026292B1 (en) 1995-12-12 2006-04-11 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
US6048964A (en) * 1995-12-12 2000-04-11 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
US6492508B1 (en) 1996-06-03 2002-12-10 United States Surgical Corp. A Division Of Tyco Healthcare Group Nucleic acids encoding extracellular matrix proteins
EP0957943B2 (en) * 1997-02-07 2008-11-26 Stryker Corporation Matrix-free osteogenic devices, implants and methods of use thereof
RU2146928C1 (ru) * 1998-07-02 2000-03-27 Белых Сергей Иванович Состав для стимуляции регенерации костных тканей
KR101072867B1 (ko) * 2001-10-31 2011-10-17 유니버시티 오브 노스 텍사스 헬스 사이언스 센터 뼈 형태발생 단백질(ｂｍｐ), ｂｍｐ 수용체 및 ｂｍｐ 결합 단백질 및 녹내장 진단 및 치료에서 그의 용도
BRPI0414448A (pt) * 2003-09-19 2006-11-14 Pfizer Prod Inc composições farmacêuticas e métodos compreendendo combinações de derivados de 2-alquilideno-19-nor-vitamina d e um agonista/antagonista de estrogênio
DK2148684T3 (da) * 2007-04-25 2013-04-22 Cytochroma Inc Fremgangsmåde til behandling af vitamin D-insufficiens og -deficiens
WO2010093925A2 (en) * 2009-02-12 2010-08-19 Stryker Corporation PERIPHERAL ADMINISTRATION OF PROTEINS INCLUDING TGF-β SUPERFAMILY MEMBERS FOR TREATMENT OF SYSTEMIC DISORDERS AND DISEASE
SG173634A1 (en) * 2009-02-12 2011-09-29 Stryker Corp COMPOSITIONS AND METHODS FOR MINIMALLY-INVASIVE SYSTEMIC DELIVERY OF PROTEINS INCLUDING TGF-ß SUPERFAMILY MEMBERS
RU2595804C1 (ru) * 2015-04-23 2016-08-27 Федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский государственный технический университет имени Гагарина Ю.А." (СГТУ имени Гагарина Ю.А.) Состав для получения стоматологической лечебно-профилактической пленки

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4833125A (en) * 1986-12-05 1989-05-23 The General Hospital Corporation Method of increasing bone mass

Also Published As

Publication number Publication date
IE921812A1 (en) 1992-12-16
JPH06508140A (ja) 1994-09-14
NO934381D0 (no) 1993-12-02
BR9206110A (pt) 1995-07-11
SK136693A3 (en) 1994-10-05
CZ282231B6 (cs) 1997-06-11
PT100567A (pt) 1994-01-31
NZ243018A (en) 1995-12-21
WO1992021365A1 (en) 1992-12-10
AU2145492A (en) 1993-01-08
EP0587751A1 (en) 1994-03-23
RU2107512C1 (ru) 1998-03-27
AU667815B2 (en) 1996-04-18
CA2110410A1 (en) 1992-12-10
CZ262493A3 (en) 1994-07-13
CA2110410C (en) 1997-04-15

Similar Documents

Publication Publication Date Title
NO934381L (no) Terapeutiske sammensetninger for osteoinduksjon
ES2033434T3 (es) Composicion cosmetica.
ES2156839T1 (es) Medicamento que contiene alginato e implante para tratar la fibrosis.
FI940932L (fi) Koostumuksia ja menetelmiä haavojen hoitamiseksi
SE8504967D0 (sv) A pharmaceutical composition and a method of treating the body
DK0920309T3 (da) Konjugeret linolensyre til bevaring eller forøgelse af mineralindhold i knogler
LV12284A (lv) No kudras izdaliti bioaktivi produkti un tos saturosas farmaceitiskas un kosmetiskas kompozicijas
RU93058532A (ru) Фармацевтическая композиция для остеоиндукции, способ генерации новой кости
GR1002802B (el) Καλλυντικες συνθεσεις και συνθεσεις περιποιησεως του δερματος
NL193399B (nl) Injecteerbare implantsamenstelling voor gebruik bij reconstructieve chirurgische behandelingen.
FI873599A7 (fi) Menetelmä ja seos luuvaurion parantamiseksi.
KR950702120A (ko) 골다공증 치료를 위한 포스포네이트의 용도(use of phosphonates for the treatment of osteoporosis)
MX9301387A (es) Metodo y composicion para el tratamiento de osteoporosis.
SE8802869D0 (sv) Combination of pyramidine derivatives and retonoids, as separate components, for inducing and stimulating hair growth and reducing its loss
JPS5533497A (en) Silaasubstituted 1*44dihydropyridine derivative
HUT66153A (en) Pharmaceutical compositions which can be used for preventing and treating of chemotherapy-induced alopecia
ATE250860T1 (de) Erhöhte stabilität von azadirachtin enthaltenden festen zubereitungen
SE8700156D0 (sv) Kosmetiska kompositioner med hudlugnande och hudgenerande effekt och forfarande for framstellning derav
ATE82850T1 (de) Verwendung von 2-pyrimidinyl-1-piperazinderivaten.
SE8403659D0 (sv) Synergistic pharmaceutical composition
SG49770A1 (en) Pharmaceutical preparation
ES2089387T3 (es) Tratamiento de la hipertension ocular con la ayuda de una combinacion sinergica.
MX9206135A (es) Metodos
AU562828B2 (en) Morphine-vitamin b12 analgesic treatment
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin